Related Experiment Videos
Determinants of ventricular arrhythmias in cardiac hypertrophy
1Department of Cardiology, Western Infirmary, Glasgow, Scotland.
Insights
Hypertension and left ventricular hypertrophy (LVH) increase the risk of ventricular arrhythmias. Multiple factors, including coronary issues and fibrosis, contribute to this heightened arrhythmia risk in patients with LVH.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Ventricular arrhythmias are more common in cardiac hypertrophy.
- Hypertension is a significant risk factor for left ventricular hypertrophy (LVH).
Purpose of the Study:
- To explore the multifactorial causes of increased ventricular arrhythmia prevalence in hypertensive patients with LVH.
Main Methods:
- Review of existing experimental and human studies on cardiac hypertrophy and arrhythmias.
- Analysis of contributing factors such as coronary artery disease, myocardial fibrosis, and metabolic abnormalities.
Main Results:
- Cardiac hypertrophy itself can be arrhythmogenic.
- Coronary artery disease and microangiopathy can cause ischemia, predisposing to arrhythmias.
- Myocardial fibrosis is linked to ventricular arrhythmias in experimental models.
- Metabolic abnormalities, including hypokalemia, may play a role, though results are conflicting.
Conclusions:
- The high prevalence of ventricular arrhythmias in hypertensive patients with LVH is likely due to a combination of factors.
- Further research is needed to clarify the role of specific factors like hypokalemia.
Abstract:
Ventricular arrhythmias occur with increased frequency in both experimental and human cardiac hypertrophy. Although the process of hypertrophy itself may be arrhythmogenic, other factors may contribute to the high prevalence of arrhythmias in hypertensive patients with left ventricular hypertrophy (LVH). Disease of the large epicardial coronary arteries or of the small intramyocardial vessels (coronary microangiopathy) may lead to myocardial ischemia and thus predispose to arrhythmia. Myocardial fibrosis, a common sequelae of cardiac hypertrophy, has also been shown to be associated with ventricular arrhythmias in experimental models. Other possible determinants of ventricular arrhythmias in this group of patients include metabolic abnormalities; studies relating to the importance of hypokalemia in particular have yielded conflicting results. Thus a number of factors may combine to explain the high prevalence of ventricular arrhythmias in hypertensive patients with LVH.